Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AKIGAI AS
AS
Active
Org 830472452
Hasselbakken 7, 0851 Oslo
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-12% vs 2023
Equity ratio
86.0%
Financial strength
Net profit 2024
NOK -6,1M
-14% vs 2023
EBITDA — year on year
NOK millions
0M
-2M
-3M
-5M
-6M
-5M
2023
-6M
-20%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -5,8M
-12%
Net profit
NOK -6,1M
-14%
Total assets
NOK 5,4M
+178%
Equity
NOK 4,6M
+601%
Employees
2
—
Company information
Legal name
AKIGAI AS
Org number
830472452
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14. desember 2022
Share capital
NOK 82 827
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets medlemmer hver for seg.
Company purpose
Utvikling og kommersialisering av legemidler og medisinske behandlingsformer, samt det som naturlig står i forbindelse med det.
Contact
Address
Hasselbakken 7, 0851 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
NOK millions
0M
-1M
-3M
-4M
-6M
-5M
2023
-6M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
−2 097
−1 731
EBITDA
−5 194
−5 818
Depreciation & amort.
−113
−222
EBIT
−5 307
−6 040
Net financials
−33
−55
Profit before tax
−5 339
−6 095
Tax
−0
−0
Net profit
−5 339
−6 095
Balance sheet
NOK thousands
Item
2023
2024
Total assets
1 933
5 381
Equity
661
4 630
Long-term debt
0
200
Short-term debt
1 272
551
Total debt
1 272
752
Financial ratios
5-year trend
EBITDA margin
-581795300.0%
This company
15.8%
Market median
-3682248834% vs market
2023
2024
Equity ratio
86.0%
This company
38.2%
Market median
+125% vs market
2023
2024
Return on equity
-131.7%
This company
18.4%
Market median
-816% vs market
2023
2024
Net profit margin
-609512900.0%
This company
8.1%
Market median
-7524850717% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-11-11 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
CK
Christian Kersten
Chief Executive Officer
Chief Executive Officer
2023
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
GE
Gunnar Evensen
Board of Directors
2024
—
—
SN
Stig Nordal
Board of Directors
2023
—
—
KH
Kjetil Hestdal
Board of Directors
2025
—
—
MG
Marte Grønlie Cameron
Chairman
2023
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Kersten Innovation As
Company
41.9%
41.9%
2024
Cameron Innovation As
Company
41.9%
41.9%
2024
Felden As
Company
16.0%
16.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Cameron Innovation As
AKIGAI AS
(this company)
Board network connections
Board members of AKIGAI AS also hold positions in
0
other companies.
Person
Role here
Other companies
Christian Kersten
Chief Executive Officer
0 companies
Gunnar Evensen
Board of Directors
0 companies
Stig Nordal
Board of Directors
0 companies
Kjetil Hestdal
Board of Directors
0 companies
Marte Grønlie Cameron
Chairman
0 companies